Non-invasive enhancement of intracortical solute clearance using transcranial focused ultrasound.
Authors: Yoo SS, Kim E, Kowsari K, Van Reet J, Kim HC, Yoon K
Transport of interstitial fluid and solutes plays a critical role in clearing metabolic waste from the brain. Transcranial application of focused ultrasound (FUS) has been shown to promote localized cerebrospinal fluid solute uptake into the brain parenchyma; however, its effects on the transport and clearance of interstitial solutes remain unknown. We demonstrate that pulsed application of low-intensity FUS to the rat brain enhances the transport of intracortically injected fluorescent tracers (ovalbumin and high molecular-weight dextran), yielding greater parenchymal tracer volume distribution compared to the unsonicated control group (ovalbumin by 40.1% and dextran by 34.6%). Furthermore, FUS promoted the drainage of injected interstitial ovalbumin to both superficial and deep cervical lymph nodes (cLNs) ipsilateral to sonication, with 78.3% higher drainage observed in the superficial cLNs compared to the non-sonicated hemisphere. The application of FUS increased the level of solute transport visible from the dorsal brain surface, with ~ 43% greater area and ~ 19% higher fluorescence intensity than the unsonicated group, especially in the pial surface ipsilateral to sonication. The sonication did not elicit tissue-level neuronal excitation, measured by an electroencephalogram, nor did it alter the molecular weight of the tracers. These findings suggest that nonthermal transcranial FUS can enhance advective transport of interstitial solutes and their subsequent removal in a completely non-invasive fashion, offering its potential non-pharmacological utility in facilitating clearance of waste from the brain.
Introduction
Purpose
Transport without BBB opening
Study Objective
To investigate whether low-intensity transcranial focused ultrasound (tFUS) can noninvasively enhance the transport and clearance of intracortically administered solutes without disrupting the blood–brain barrier (BBB).
Animal model / Human subject
Rat (Rattus norvegicus); strain: None; age: None; sex: None
Disease model
healthy
MRI or image guidance method
ultrasound imaging
Targeted brain region(s)
Cerebral cortex
Cargo name and characteristics
Ovalbumin (OA, 45 kDa protein) and FITC-dextran (2000 kDa fluorescent polysaccharide/macromolecule), used as model interstitial tracers to evaluate solute transport and clearance.
Outcomes and Safety
Summary of Outcomes
tFUS significantly enhanced intracortical transport of OA (40.1%) and FITC-dextran (34.6%), increased OA drainage to superficial cervical lymph nodes by 78.3%, and promoted brain solute clearance without BBB opening or neuronal stimulation.
Duration of biological effect
Enhanced solute transport was observed after 30 minutes of sonication, while increased lymphatic drainage persisted during 60 minutes of FUS exposure and throughout the experimental observation period.
Safety-related matter
tFUS produced no BBB disruption, neuronal activation, tissue damage, hemorrhage, apoptosis, ischemia, or glial activation, with negligible thermal elevation (<0.03 °C) and no alteration of tracer molecular weight.
Brain Region
Ultrasound Parameters
FUS Frequency
200 kHz
FUS Intensity
5 W/cm2
FUS Pressure
770 kPa
FUS Mode
pulsed
Pulse duration
100 ms
Duration of a single FUS session
30 min
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency
Single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search